VireturnRevenue
9.9B USDAnnual · FY 2025BIIB
BIOGEN INC.
Operating income
2.8B USDAnnual · FY 2021Net income
1.3B USDAnnual · FY 2025Total assets
29.4B USDAnnual · FY 2025Equity
18.3B USDAnnual · FY 2025Operating cash flow
2.2B USDAnnual · FY 2025BIIB · Chart
Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.
Reported financial information
Revenue
USD
9.9B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 11B USD |
| FY 2022 | 10.2B USD |
| FY 2023 | 9.8B USD |
| FY 2024 | 9.7B USD |
| FY 2025 | 9.9B USD |
Operating income
USD
2.8B USD
Period data
| Period | Value |
|---|---|
| FY 2017 | 5.3B USD |
| FY 2018 | 5.9B USD |
| FY 2019 | 7B USD |
| FY 2020 | 4.6B USD |
| FY 2021 | 2.8B USD |
Net income
USD
1.3B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 1.6B USD |
| FY 2022 | 3B USD |
| FY 2023 | 1.2B USD |
| FY 2024 | 1.6B USD |
| FY 2025 | 1.3B USD |
Total assets
USD
29.4B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 23.9B USD |
| FY 2022 | 24.6B USD |
| FY 2023 | 26.8B USD |
| FY 2024 | 28B USD |
| FY 2025 | 29.4B USD |
Equity
USD
18.3B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 11B USD |
| FY 2022 | 13.4B USD |
| FY 2023 | 14.8B USD |
| FY 2024 | 16.7B USD |
| FY 2025 | 18.3B USD |
Operating cash flow
USD
2.2B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 3.6B USD |
| FY 2022 | 1.4B USD |
| FY 2023 | 1.5B USD |
| FY 2024 | 2.9B USD |
| FY 2025 | 2.2B USD |
Revenue growth
%
2.2%
Period data
| Period | Value |
|---|---|
| FY 2021 | -18.3% |
| FY 2022 | -7.4% |
| FY 2023 | -3.3% |
| FY 2024 | -1.6% |
| FY 2025 | 2.2% |
Operating income growth
%
-37.6%
Period data
| Period | Value |
|---|---|
| FY 2017 | 3.8% |
| FY 2018 | 10.2% |
| FY 2019 | 19.6% |
| FY 2020 | -35.4% |
| FY 2021 | -37.6% |
Net income growth
%
-20.8%
Period data
| Period | Value |
|---|---|
| FY 2021 | -61.1% |
| FY 2022 | 95.8% |
| FY 2023 | -61.9% |
| FY 2024 | 40.6% |
| FY 2025 | -20.8% |
Operating margin
%
25.9%
Period data
| Period | Value |
|---|---|
| FY 2017 | 43.6% |
| FY 2018 | 43.8% |
| FY 2019 | 49% |
| FY 2020 | 33.8% |
| FY 2021 | 25.9% |
Net margin
%
13.1%
Period data
| Period | Value |
|---|---|
| FY 2021 | 14.2% |
| FY 2022 | 29.9% |
| FY 2023 | 11.8% |
| FY 2024 | 16.9% |
| FY 2025 | 13.1% |
Return on assets
%
4.5%
Period data
| Period | Value |
|---|---|
| FY 2021 | 6.4% |
| FY 2022 | 12.6% |
| FY 2023 | 4.5% |
| FY 2024 | 5.9% |
| FY 2025 | 4.5% |
Debt/Equity
x
0.61x
Period data
| Period | Value |
|---|---|
| FY 2021 | 1.18x |
| FY 2022 | 0.83x |
| FY 2023 | 0.81x |
| FY 2024 | 0.68x |
| FY 2025 | 0.61x |